Leaders in Learning: Publications of Faculty & Staff


 Clinical Neurological Sciences: 1999-2000

 

BARNETT, H. J. M.

Del Sette, M., M. Eliasziw, J.Y. Streifler, V.C. Hachinski, A.J. Fox, and H.J.M. Barnett. 2000. Internal borderzone infarction. Stroke 31: 631-636.

Taylor, D.W., H.J.M. Barnett, R.D. Haynes, G.G. Ferguson, D.L. Sackett, K.E. Thorpe, D. Simard, F.L. Silver, V.C. Hachinski, et al. 1999. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid. The Lancet 353: 2179-2184.

Taylor, W.D., H.J.M. Barnett, R.B. Haynes, G.G. Ferguson, D.L. Sackett, K.E. Thorpe, D. Simard, F.L. Silver, V.C. Hachinski, G.P. Claggett, R. Barnes, and J.D. Spence. 1999. A randomized trial of low and high dose acetylsalicylic acid for patients undergoing carotid endarterectomy. Lancet 353: 2179-2184.

 

BLUME, W. T.

Blume, W.T. 2000. EEG and Epilepsy. Comprehensive Epilepsy Course. Huron, Ohio: 24 June 2000. [Syllabus].

Blume, W.T. 2000. EEG Characteristics of Primary Generalised Epilepsies. Canadian Congress of Neurological Sciences. Ottawa, Ontario: 13 June 2000-17 June 2000. [Syllabus].

Blume, W.T. 2000. Normal EEG from Infants to Adults. American Academy of Neurology Course. San Diego, California: 29 April 2000-6 May 2000. [Syllabus].

Blume, W.T. 2000. Normal EEG in Children. Annual American Clinical Neurophysiology Society Course. Montreal, PQ: 20 September 2000-21 September 2000. [Syllabus].

Blume, W.T. 2000. Surgical treatment of epilepsy. Merritt-Putnam Neurology Residents' Course. Aylmer, Quebec: 25 February 2000-26 February 2000.

Blume, W.T. 2000. The team approach to treating epilepsy: when do we need it? Epilepsy: Problem Solving in Clinical Practice. D. Schmidt, and C. Schachter. London, UK: Martin Dunitz. 469-474.

Blume, W.T., and P. Hwang. 2000. Pediatric candidates for temporal lobe epilepsy surgery. Canadian Journal Neurological Sciences 27 (Suppl 1): S14-S19.

Blume, W.T., and S. Wiebe. 2000. Occipital lobe epilepsies. Advances in Neurology: Neocortical Epilepsies 84: 173-187.

Jones, D.C., and W.T. Blume. 2000. Pattern-evoked potential latencies from central and peripheral visual fields. Journal of Clinical Neurophysiology 17 (1): 68-76.

Manchanda, R., A. Freeland, B. Schaefer, R.S. McLachlan, and W.T. Blume. 1999. Auras, seizure focus and psychiatric disorders. Neuropsychiatry, Neuropsychology, and Behavioural Neurology 13 (1): 13-19.

 

BOLTON, C. F.

Ashworth, N.L., D.W. Zochodne, A.F. Hahn, N. Pillay, C. Chalk, T. Benstead, V. Bril, T.E. Feasby, and C.F. Bolton. 2000. The impact of plasma exchange on indices of primary demyelination in chronic inflammatory demyelinating polyradiculo-neuropathy (CIDP). Muscle & Nerve 23: 206-210.

Bolton, C.F., and G.B. Young. 1999. Hospitalist Neurology. Nephrology. M. Samuels. Boston: Butterworth-Heinemann. 231-254.

Hahn, A.F., C.F. Bolton, C.M. White, W.F. Brown, S.E. Tuuha, C.C. Tan, and P.J. Ainsworth. 1999. Genotype/phenotype correlations in the x-linked dominant Charcot-Marie-Tooth disease. Annals of the New York Academy of Sciences 883: 366-382.

Young, G.B., and C.F. Bolton. 1999. Electrophysiologic Evaluation of Patients in the Intensive Care Unit. Electrodiagnosis in Clinical Neurology. 4th ed. M. Aminoff. New York, NY: Churchill Livingston. 655-679.

Zifko, U., M.W. Nicolle, W. Grisold, and C.F. Bolton. 1999. Repetitive phrenic nerve stimulation in myasthenia gravis. Neurology 53: 1083-1087.

 

CECHETTO, D. F.

King, A.B., R.S. Menon, V.C. Hachinski, and D.F. Cechetto. 1999. Human forebrain activation by visceral stimuli. The Journal of Comparative Neurology 413: 572-582.

 

COOPER, P.E.

Demaerschalk, B.M., and P.E. Cooper. 2000. Drug-induced neurologic disorders. Melmon & Morrelli's Clinical Pharmacology. 4th ed. Carruthers S. G., B.B. Hoffman, K.L. Melmon, and D.W. Nierenberg. New York, NY: McGraw-Hill. 480-488.

 

DERRY, P. E.

Derry, P.E., and S. Wiebe. 2000. Psychological adjustment to success and to failure following epilepsy surgery. Canadian Journal of Neurological Sciences 27 (Suppl 1): 116-120.

Wiebe, S., and P.E. Derry. 2000. Measuring quality of life in epilepsy surgery patients. Canadian Journal of Neurological Sciences 27 (Suppl 1): 111-115.

 

FERGUSON, G. G.

Lownie, S.P., C.G. Drake, S.J. Peerless, G.G. Ferguson, and D.M. Pelz. 2000. Clinical presentation and management of giant anterior communicating region aneurysms. Journal of Neurosurgery 92 (Feb): 267-277.

Taylor, D.W., H.J.M. Barnett, R.D. Haynes, G.G. Ferguson, D.L. Sackett, K.E. Thorpe, D. Simard, F.L. Silver, V.C. Hachinski, and et al. 1999. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid. The Lancet 353: 2179-2184.

Taylor, W.D., H.J.M. Barnett, R.B. Haynes, G.G. Ferguson, D.L. Sackett, K.E. Thorpe, D. Simard, F.L. Silver, V.C. Hachinski, G.P. Claggett, R. Barnes, and J.D. Spence. 1999. A randomized trial of low and high dose acetylsalicylic acid for patients undergoing carotid endarterectomy. Lancet 353: 2179-2184.

 

FOX, A. J.

Del Sette, M., M. Eliasziw, J.Y. Streifler, V.C. Hachinski, A.J. Fox, and H.J.M. Barnett. 2000. Internal borderzone infarction. Stroke 31: 631-636.

Lownie, S.P., D.M. Pelz, and A.J. Fox. 2000. Endovascular therapy of a large vertebral artery aneurysm using stent and coils. Canadian Journal of Neurological Sciences 27: 162-165.

 

GRACE, G. M.

Kubu, C.S., G.M. Grace, and A.G. Parrent. 2000. Neuropsychological outcome following stereotactic lesioning of the posteroventral internal globus pallidus: the role of side of surgery and age of disease onset. 92: 384-389.

Strong, M.J., G.M. Grace, J.B. Orange, H.A. Leeper, R. Menon, and C. Aere. 1999. A prospective study of cognitive impairment in ALS. Neurology 53: 1665-1670.

 

HACHINSKI, V.C.

Bowler, J.V., R. Steenhuis, and V.C. Hachinski. 1999. Conceptual background to vascular cognitive impairment. Alzheimier Disease and Associated Disorders 13 (3): S30-S37.

Del Ser, T., V.C. Hachinski, H. Merskey, and D.G. Munoz. 1999. An autopsy-verified study of the effect of education on degenerative dementia. Brain 122: 2309-2319.

Del Sette, M., M. Eliasziw, J.Y. Streifler, V.C. Hachinski, A.J. Fox, and H.J.M. Barnett. 2000. Internal borderzone infarction. Stroke 31: 631-636.

Desmond, D.W., T. Erkinjuntti, M. Sano, J.L. Cummlings, J.V. Bowler, F. Pasquier, J.T. Moroney, S.H. Ferris, Y. Stern, P.S. Sachdev, and V.C. Hachinski. 1999. The cognitive syndrome of vascular dementia: Implications for clinical trials. Alzheimer Disease and Associated Disorders 13 (3): S21-S29.

Hachinski, V.C., and D.G. Munoz. 1997. Cerebrovascular pathology in Alzheimer's disease: Cause, effect, or epiphenomenon? Annals of the New York Academy of Sciences: Cerebrovascular Pathology in Alzheimer's Disease 826: 1-5.

King, A.B., R.S. Menon, V.C. Hachinski, and D.F. Cechetto. 1999. Human forebrain activation by visceral stimuli. The Journal of Comparative Neurology 413: 572-582.

Munoz, D.G., G.R. Ganapathy, M. Eliasziw, and V.C. Hachinski. 2000. Educational attainment and socioeconomic status of patients with autopsy-confirmed alzheimer disease. Archives of Neurology 57: 85-89.

Pantoni, L., D. Leys, F. Fazekas, W.T. Longstreth Jr, D. Inzitari, A. Wallin, M. Filippi, P. Scheltens, T. Erkinjuntti, and V.C. Hachinski . 1999. Role of white matter lesions in cognitive imipairment of vascular origin. Alzheimer Disease and Associated Disorders 13 (3): S49-S54.

Rockwood, K., J. Bowler, T. Erkinjuntti, V.C. Hachinski, and A. Wallin. 1999. Subtypes of vascular dementia. Alzheimer Disease and Associated Disorders 13 (3): S59-S65.

Rockwood, K., C. Wentzel, V.C. Hachinski, D.B. Hogan, C. MacKnight, and I. McDowell. 2000. Prevalence and outcomes of vascular cognitive impairment. Neurology 54: 447-451.

Taylor, D.W., H.J.M. Barnett, R.D. Haynes, G.G. Ferguson, D.L. Sackett, K.E. Thorpe, D. Simard, F.L. Silver, V.C. Hachinski, et al. 1999. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid. The Lancet 353: 2179-2184.

Taylor, W.D., H.J.M. Barnett, R.B. Haynes, G.G. Ferguson, D.L. Sackett, K.E. Thorpe, D. Simard, F.L. Silver, V.C. Hachinski, G.P. Claggett, R. Barnes, and J.D. Spence. 1999. A randomized trial of low and high dose acetylsalicylic acid for patients undergoing carotid endarterectomy. Lancet 353: 2179-2184.

 

HAHN, A. F.

Ashworth, N.L., D.W. Zochodne, A.F. Hahn, N. Pillay, C. Chalk, T. Benstead, V. Bril, T.E. Feasby, and C.F. Bolton. 2000. The impact of plasma exchange on indices of primary demyelination in chronic inflammatory demyelinating polyradiculo-neuropathy (CIDP). Muscle & Nerve 23: 206-210.

Bulman, D., K.A. Scoggan, M.D. van Oene, M.W. Nicolle, A.F. Hahn, L.L. Tollar, and G.C. Ebers. 1999. Identification of a novel sodium channel mutation in a family with hypokalemic periodic paralysis. Neurology 53: 1932-1936.

Bulman, D., K.A. Scoggan, M.D. van Oene, M.W. Nicolle, A.F. Hahn, L.L. Tollar, and G.C. Ebers. 1999. A novel sodium channel mutation in a family with hypokalemic periodic paralysis. Neurology 53: 1932-1936.

Hahn, A.F. 2000. Resurgence of diphtheria in the newly independent states of the former Soviet Union - A reminder of risk. Journal of Neurology, Neurosurgery, and Psychiatry 67: 426.

Hahn, A.F., C.F. Bolton, C.M. White, W.F. Brown, S.E. Tuuha, C.C. Tan, and P.J. Ainsworth. 1999. Genotype/phenotype correlations in the x-linked dominant Charcot-Marie-Tooth disease. Annals of the New York Academy of Sciences 883: 366-382.

Tawil, R., M.P. McDermott, R. Brown, B. Shapiro, L.J. Ptacek, P.G. McManis, M.C. Dalakas, S. Specter, J.R. Mendell, A.F. Hahn, R.C. Griggs, and The Working Group on Periodic Paralysis. 2000. Randomized trials of dichlorphenamide in the periodic paralyses. Annals of Neurology 23: 46-53.

Thomas, F.P., T.J. Geller, A.F. Hahn, L. Gutmann, X.L. Huang, H. Wu, H.E. Wyandt, and R.V. Lebo. 1999. Complex neurological phenotypes in three CMT1A patients: One with partial chromosome 5p trisomy and epilepsy, two with McArdle disease. Annals of the New York Academy of Sciences 883: 472-476.

 

JOG, M. S.

Jog, M.S., Y. Kubota, C. Conolly, V. Hillegaart, and A. Graybiel. 1999. Building neural representations of habits. Science 286: 1745-1749.

 

KERTESZ, A.

Fukui, T., and A. Kertesz. 2000. Volumetric study of lobar atrophy in Pick complex and Alzheimer's disease. Journal of the Neurological Sciences 174: 111-121.

Fukui, T., A. Kertesz, and M. Kawamura. 1999. Quantitative study of cerebral atrophy patterns in Pick complex and Alzheimer's disease. Japanese Journal of Neuropsychology 15: 219-228.

Fukui, T., A. Kertesz, and M. Kawamura. 1999. Role of cognitive examinations in the realm of degenerative dementia. High Brain Function Research 19: 252-260.

Kertesz, A. 2000. Alien hand, free will and Arnold Pick. Canadian Journal of Neurological Sciences 27: 183. Editorial.

Kertesz, A. 2000. American Academy of Neurology Antidementia Drug Review. ID Weekly Highlights (May): 43-46.

Kertesz, A. 2000. Behavioral and cognitive disorders. Prognosis of Neurological Disorders. 2nd ed. R.W. Evans, D.S. Baskin, and F.M. Yatsu. New York, NY: Oxford University Press. 610-622.

Kertesz, A. 1999. Clinical and pathological variability and similarity in degenerative disease with P301 tau mutations. Neurology Network 3: 313-315. Editorial commentary.

Kertesz, A. 2000. Corticobasal degeneration. Journal of Neurology, Neurosurgery and Psychiatry 68: 275. Editorial commentary.

Kertesz, A. 2000. Primary Progressive Aphasia. Neurobehavioral of Language and Cognition: Studies of Normal Aging and Brain Damage. L.T. Connor, and K. Obler. Norwell, MA: Kluwer Academic. 149-158.

Kertesz, A., T. Kawarai, E. Rogaeva, P. St. George-Hyslop, P. Poorkaj, T.D. Bird, and D.G. Munoz. 2000. Familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions. Neurology 54: 818-827.

Kertesz, A., and D.G. Munoz. 1999. Diagnostic controversies: Is CBD part of the Pick Complex? Advances in Neurology: Corticobasal Degeneration 82: 223-231.

Kertesz, A., and D.G. Munoz. 1999. Pick's Disease, Frontotemporal Dementia. Alzheimer Disease. R.D. Terry, R. Katzman, K.L. Bick, and S.S. Sisodia. Philadelphia, PA: Lippincott-Raven. 133-145.

Kertesz, A., N. Nadkarni, W. Davidson, and A. Thomas. 2000. The Frontal Behavioural Inventory in the differential diagnosis of frontotemporal dementia. Journal of International Neuropsychological Society 6: 460-468.

Kertesz, A., and J.B. Orange. 2000. Primary progressive aphasia - the future of neurolinguistic and biologic characterization. Brain and Language 71: 116-119.

Orange, J.B., and A. Kertesz. 2000. Discourse analyses and dementia. Brain and Language 71: 172-174.

Stodilka, R.Z., B.J. Kemp, F.S. Prato, A. Kertesz, D. Kuhl, and R.L. Nicholson. 2000. Scatter and attenuation correction for brain SPECT using attenuation distributions inferred from a head atlas. Journal of Nuclear Medicine 41: 1569-1578.

 

KUBU, C. S.

Kubu, C.S., G.M. Grace, and A.G. Parrent. 2000. Neuropsychological outcome following stereotactic lesioning of the posteroventral internal globus pallidus: the role of side of surgery and age of disease onset. 92: 384-389.

 

LEE, D. H.

Kremenchutzky, M., D.H. Lee, G.P.A. Rice, and G.C. Ebers. 2000. Diagnostic brain MRI findings in primary progressive MS. Multiple Sclerosis 6 (2): 61-85.

Sahjpaul, R.L., and D.H. Lee. 1999. Fatal Reaction to inadvertent intrathecal entry of ionic contrast medium during nephrography. Review Series. Urology, Helix Communications AB 1: 16-17.

Sahjpaul, R.L., and D.H. Lee. 1999. Infratentoria Subdural Empyema, Pituitary Abscess, and Septic Cavernous Sinus Thrombophlebitis Secondary to Paransal Sinusitis, Case Report. Neurosurgery 44 (4): 864-868.

 

LOWNIE, S. P.

Lownie, S.P. 1999. Coil occlusion of basilar bifurcation aneurysms: the shape of things to come. Canadian Journal of Neurological Sciences 26: 170-171. Editorial.

Lownie, S.P., C.G. Drake, S.J. Peerless, G.G. Ferguson, and D.M. Pelz. 2000. Clinical presentation and management of giant anterior communicating region aneurysms. Journal of Neurosurgery 92 (Feb): 267-277.

Lownie, S.P., D.M. Pelz, and A.J. Fox. 2000. Endovascular therapy of a large vertebral artery aneurysm using stent and coils. Canadian Journal of Neurological Sciences 27: 162-165.

Lownie, S.P., and R.L. Sahjpaul. 2000. Stent angioplasty of traumatic superior sagittal sinus occlusion. 35th Meeting the Canadian Congress of Neurological Surgeons. Ottawa, Ontario.

Pelz, D.M., and S.P. Lownie. 2000. Carotid angioplasty and stenting: current status. Canadian Medical Association Journal 162 (10): 1451-1454.

 

MCLACHLAN, R.S.

Bayliff, C., P. Camfield, S. Cowan, A. Guberman, S. Lovell, R.S. McLachlan, and G.B. Young. 1999. Anti-epileptic Drug Treatment. CPS 1999. 34th ed. G. Gillis. Toronto, ON: Webcom. L45-L47.

Manchanda, R., A. Freeland, B. Schaefer, R.S. McLachlan, and W.T. Blume. 1999. Auras, seizure focus and psychiatric disorders. Neuropsychiatry, Neuropsychology, and Behavioural Neurology 13 (1): 13-19.

 

MEGYESI, J. F.

Cook, D.A., B. Vollrath, J.F. Megyesi, and J.M. Findlay. 1999. The effects of oxyhemoglobin in vascular smooth muscle depend on free radical formation. Cerebral Vasospasm: Proceedings of the VIth International Conference on Cerebral Vasospasm. N. Dorsch. Leichhardt Oslington Consulting. 19-21.

Megyesi, J.F., and J.M. Findlay. 1999. Comment on: Effect of ebselen on contractile responses in perfused rabbit basilar artery. Neurosurgery 44: 370-378.

Megyesi, J.F., J.M. Findlay, B. Vollrath, D. Cook, and M.H. Chen. 1999. In Vivo balloon angioplasty prevents experimental vasospasm. Cerebral Vasospasm: Proceedings of the VIth International Conference on Cerebral Vasospasm. N. Dorsch. Leichhardt: Oslington Consulting. 128-130.

Megyesi, J.F., J.M. Findlay, B. Vollrath, D. Cook, and M.H. Chen. 1999. Long-term effects of in vivo balloon angioplasty. Cerebral Vasospasm: Proceedings of the VIth International Conference on Cerebral Vasospasm. N. Dorsch. Leichhardt: Oslington Consulting PTY. 131-133.

Megyesi, J.F., B.V. Vollrath, D.A. Cook, M.H. Chen, and J.M. Findlay. 1999. Long-term effects of in vivo balloon angioplasty on normal and vasospastic canine carotid. Journal of Neurosurgery 91: 100-108.

Megyesi, J.F., B.V. Vollrath, D.A. Cook, and J.M. Findlay. 2000. In vivo animal models of cerebral vasospasm: a review. Neurosurgery 46: 448-461.

Ohkuma, H., I. Parney, J.F. Megyesi, A. Ghahary, and J.M. Findlay. 1999. Antisense preproendothelin-oligo DNA therapy for vasospasm in a canine model of SAH. Journal of Neurosurgery 90: 1105-1114.

 

MOULIN, D. E.

Mersky, H., and D.E. Moulin. 1999. Biopsychosocial Perspectives. Handbook of Chronic Pain Syndromes. A. Block, E. Kremer, and E. Fernandez. New Jersey: Lawrence Erlbaum Associates. 149-163.

Moulin, D.E. 1999. Cancer Pain Assessment and Treatment. Pain Research Management 4: 201.

Moulin, D.E. 2000. Opioid analgesics in the management of neuropathic pain. Pain Research and Management 5: 89-91.

Moulin, D.E. 2000. Pharmacologic management of neuropathic pain. American Academy of Neurology Therapy Course. 87-101. [Syllabus] .

Moulin, D.E. 2000. Systemic drug treatment for chronic musculoskeletal pain. Report of the Chronic Pain Expert Advisory Panel Ontario Workplace Safety and Insurance Board. Toronto, ON. 169-180.

Moulin, D.E. 1999. Tramadol for the treatment of the pain of diabetic neuropathy. Neurology 52: 1301.

Zaza, C., L. Reyno, and D.E. Moulin. 2000. The multidimensional pain inventory profiles in patients with chronic cancer-related pain: an examination of generalizability. Pain 87: 75-82.

 

NICOLLE, M. W.

Bulman, D., K.A. Scoggan, M.D. van Oene, M.W. Nicolle, A.F. Hahn, L.L. Tollar, and G.C. Ebers. 1999. Identification of a novel sodium channel mutation in a family with hypokalemic periodic paralysis. Neurology 53: 1932-1936.

Bulman, D., K.A. Scoggan, M.D. van Oene, M.W. Nicolle, A.F. Hahn, L.L. Tollar, and G.C. Ebers. 1999. A novel sodium channel mutation in a family with hypokalemic periodic paralysis. Neurology 53: 1932-1936.

Nicolle, M.W. 2000. Myasthenia Gravis. Melmon & Morelli's Clinical Pharmacology Basic Principles in Therapeutics. 4th ed. Carruthers S. G. , B.B. Hoffman, K.L. Melmon, and D.W. Neirenberg. New York, NY: McGraw-Hill. 460-479.

Wang, D., and M.W. Nicolle. 1999. Generation of acetylcholine receptor-specific human T cell lines using heterobifunctional antibody-targeted antigen presentation. Journal of Neuroimmunology 99: 114-121.

Young, G.B., and M.W. Nicolle. 1999. Normal Physiology of the Nervous System. Oxford Textbook of Critical Care. A.R. Webb, M. Shapiro, M. Singer, and P.M. Suter. Oxford University Press. 433-437.

Zifko, U., M.W. Nicolle, W. Grisold, and C.F. Bolton. 1999. Repetitive phrenic nerve stimulation in myasthenia gravis. Neurology 53: 1083-1087.

 

NORRIS, J.W.

Davis, S.M., K.R. Lees, G.W. Albers, H.C. Diener, S. Markabi, G. Karlsson, J.W. Norris, and The ASSIST Investigators. 2000. Selfotel in acutre ischemic stroke possible neurotoxic effects of an NMDA antagonist. Stroke 31: 347-354.

 

PARRENT, A.G.

Kubu, C.S., G.M. Grace, and A.G. Parrent. 2000. Neuropsychological outcome following stereotactic lesioning of the posteroventral internal globus pallidus: the role of side of surgery and age of disease onset. 92: 384-389.

Parrent, A.G. 2000. Endoscopic fenestration of the choroidal fissure for treatment of trapped temporal horn. Journal of Neurosurgery 93 (Nov): 891-894.

Parrent, A.G. 1999. Stereotactic radiofrequency ablation for the treatment of gelastic seizures associated with hypothalamic hematoma. Neurosurgery 91: 881-884.

Parrent, A.G. 2000. Stereotactic surgery for temporal lobe epilepsy. Canadian Journal of Neurological Sciences 27 (Suppl 1): S79-S84.

 

PELZ, D. M.

Lownie, S.P., C.G. Drake, S.J. Peerless, G.G. Ferguson, and D.M. Pelz. 2000. Clinical presentation and management of giant anterior communicating region aneurysms. Journal of Neurosurgery 92 (Feb): 267-277.

Lownie, S.P., D.M. Pelz, and A.J. Fox. 2000. Endovascular therapy of a large vertebral artery aneurysm using stent and coils. Canadian Journal of Neurological Sciences 27: 162-165.

Pelz, D.M., and S.P. Lownie. 2000. Carotid angioplasty and stenting: current status. Canadian Medical Association Journal 162 (10): 1451-1454.

 

RICE, G.P.A.

Ebers, G.C., W.J. Koopman, W. Hader, A.D. Sadovnick, M. Kremenchutzky, P. Mandalfino, D.M. Wingerchuck, J. Baskerville, and G.P.A. Rice. 2000. The natural history of multiple sclerosis: a geographically based study. 8. Familial multiple sclerosis. Brain 123 (3): 641-649.

Filippi, M., M. Rovaris, G.P.A. Rice, et al. 2000. The effect of cladribine on T1 'black hole' changes in progressive multiple sclerosis. Journal of the Neurological Sciences 176 (May): 42-44.

Grima, D.T., G.W. Torrance, G. Francis, G.P.A. Rice, A.J. Rosner, and L. Laforturne. 2000. Cost and health related quality of life consequences of multiple sclerosis. Multiple Sclerosis 6 (2): 91-98.

Kremenchutzky, M., D.A. Cottrell, G.P.A. Rice, W. Hader, J. Baskerville, W. Koopman, and G.C. Ebers. 1999. The natural history of multiple sclerosis: a geographically based study 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation. Brain 122: 1941-1949.

Kremenchutzky, M., D.H. Lee, G.P.A. Rice, and G.C. Ebers. 2000. Diagnostic brain MRI findings in primary progressive MS. Multiple Sclerosis 6 (2): 61-85.

Li, D.K., D.W. Paty, G.P.A. Rice, and The PRISMS Study Group. 1999. Magnetic resonance imaging results of the PRISMS trial: a randomized, double-blind, placebo-controlled study of interferon-beta 1a in relapsing-remitting multiple sclerosis Preventions of Relapses and disability by interferon-ß 1a subcutaneously in MS. Annals of Neurology 46 (2): 197-206.

Oger, J., M. Freedman, G.P.A. Rice, and The Canadian M.S. Clinics Network Canada. 1999. Consensus statement of the Canadian MS Clinics Network on: the use of disease modifying agents in multiple sclerosis. Canadian Journal of Neurological Sciences 26 (4): 274-275.

Rice, G.P.A. 1999. Cladribine (Chapter 22). Multiple Sclerosis Therapeutics. R.A. Rudick, and D.E. Goodkin. Martin Dunitz Publishers. 299-307.

Rice, G.P.A. 1999. Continuum. Multiple Sclerosis, American Academy of Neurology. Lippincott Williams & Wilkins Publishers.

Rice, G.P.A. 1999. Treatment of Secondary Progressive Multiple Sclerosis. BioDrugs 12 (4): 267-277.

Rice, G.P.A., G. Comi, M. Filippi, The Cladribine Clinical Study Group, and The Cladribine MRI Group. 2000. Cladribine and progressive MS; Clinical and MRI outcomes of a multicenter controlled trial. Neurology 54 (March): 1145-1155.

Rice, G.P.A., and The Lenercept M. S. Study Group. 1999. TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology 53 (3): 457-465.

Rice, G.P.A., J. Oger, P. Duquette, G.S. Francis, M. Belanger, S. Laplante, and J.F. Grenier. 1999. Treatment with Interferon ß-1b Improves Quality of Life in Multiple Sclerosis. Canadian Journal Neurological Sciences 26 (4): 276-282.

Rice, G.P.A., N. Risch, and G. Ebers. 1999. Genetics and Male Sexual Orientation Technical Comment. Science 285 (Aug): 803.

 

SAHJPAUL, R. L.

Lownie, S.P., and R.L. Sahjpaul. 2000. Stent angioplasty of traumatic superior sagittal sinus occlusion. 35th Meeting the Canadian Congress of Neurological Surgeons. Ottawa, Ontario:

Sahjpaul, R.L. 2000. Awake Craniotomy in Temporal Lobe Epilepsy: Current indications, techniques and controversy. Neurosurgery, Indian Neurosciences Update 46.

Sahjpaul, R.L., and D.H. Lee. 1999. Fatal Reaction to inadvertent intrathecal entry of ionic contrast medium during nephrography. Review Series. Urology, Helix Communications AB 1: 16-17.

Sahjpaul, R.L., and D.H. Lee. 1999. Infratentoria Subdural Empyema, Pituitary Abscess, and Septic Cavernous Sinus Thrombophlebitis Secondary to Paransal Sinusitis, Case Report. Neurosurgery 44 (4): 864-868.

 

SPENCE, J. D.

Badner, N.H., W.S. Beattie, D. Freeman, and J.D. Spence. 2000. Nitrous Oxide-Induced Increased Homocysteine Concentrations Are Associated with Increased Postoperative Myocardial Ischemia in Patients Undergoing Carotid Endarterectomy. Anesthesia and Analgesia 91: 1073-1079.

Bailey, D.G., J.M.O. Arnold, and J.D. Spence. 2000. Inhibitors in the Diet: Grapefruit Juice - Drug Interactions. Metabolic Drug Interactions. R. Levy, and B. Rasmussen. 661-669.

Conlin, P.R., J.D. Spence, B. Williams, A.B. Ribeiro, I. Saito, C. Benedict, and A.M.G. Bunt. 2000. American Journal of Hypertension 13: 418-426.

Dresser, G.K., J.D. Spence, and D.G. Bailey. 2000. Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. Clinical Pharmacokinetics 38 (1): 41-57.

Hackam, D.G., J.C. Peterson, and J.D. Spence. 2000. What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14mmol/L. American Journal of Hypertension 13: 105-110.

Hegele, R.A., M.R. Ban, C.M. Anderson, and J.D. Spence. 2000. Infection-susceptibility alleles of Mannose-binding lectin are associated with increased carotid plaque area. Atherosclerosis 150 (1): P14.

Hegele, R.A., M.R. Ban, C.M. Anderson, and J.D. Spence. 2000. Infection-susceptibility alleles of mannose-binding lectin are associated with increased carotid plaque area. Journal of Investigative Medicine 48: 198-202.

Kurowska, E.M., N.M. Borradaile, J.D. Spence, and K.K. Carroll. 2000. Hypocholesterolemic effects of dietary citrus juices in rabbits. Nutrition Research 20 (1): 121-129.

Merino, J.G., and J.D. Spence. 2000. Avances en la prevencion de la enfermedad cerebrovascular. Revista Argentina de Medicina 11: 219-229.

Merino, J.G., and J.D. Spence. 2000. Commentarjos al articulo factores de riesgo cardiovascular y aterosclerosis carotidea detectada por ultrasonografia. Salud Publica de Mexico 42: 173-174.

Quintana, I., D. Freeman, C. Galarza, A. Murua, J.D. Spence, and L. Kordich. 2000. Validation of an enzyme immunoassay for the determination of total homocystein in plasma. Blood Coagulation and Fibrinolysis 11: 1-4.

Spence, J.D. 1999. Advances in Atherosclerosis: New understanding based on endothelial function. Current Review of Cerebrovascular Disease. 3rd ed. M. Fisher, and J. Bogousslavskky. Philadelphia, PA: Current Medicine. 1-13.

Spence, J.D. 2000. Commentary on "Berger, K., Ajani, U.A., Gaziano, J.M., et al. Light-to-moderate alcohol consumption reduced the risk of total stroke and ischemic stroke among male physicians. New England Journal of Medicine, 1999; 341: 1557-1564". Evidence-based Cardiovascular Medicine 4: 31.

Spence, J.D. 1999. The efficacy of angiotensin II antagonists in hypertension. Canadian Journal of Cardiology 15 (Suppl F): 33F-35F.

Spence, J.D. 1999. Experience of life. Canadian Medical Association Journal 160: 1287-1288.

Spence, J.D. 1999. Fruitful discussions about drug interactions. Canadian Medical Association Journal 161 (8): 946.

Spence, J.D. 2000. Management of resistant hypertension in patients with carotid stenosis: High prevalence of renovascular hypertension. Cerebrovascular diseases 10: 249-254.

Spence, J.D. 1999. Physiologic tailoring of therapy for resistant hypertension: 20 years' experience with stimulated renin profiling. American Journal of Hypertension 12: 1077-1083.

Spence, J.D. 1999. Withholding treatment in white-coat hypertension: Wishful thinking. Canadian Medical Association Journal 161: 275-276.

Spence, J.D., P.A. Barnett, D.E. Bulman, and R. Hegele. 1999. Atherosclerosis 144: 429-434.

Spence, J.D., and The Heart Outcomes Prevention Evaluation Study Investigators. 2000. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. New England Journal of Medicine 342: 145-153.

Spence, J.D., M. Huff, and P.A. Barnett. 2000. Effects of indapamide versus hydrochlorothiazide on plasma lipids and lipoproteins in hypertensive patients. Canadian Journal of Clinical Pharmacology 7: 32-37.

Spence, J.D., C. Munoz, M.W. Huff, and S. Tokmakjian. 2000. Effect of amlodipine on hemodynamic and endocrine responses to mental stress. American Journal of Hypertension 13: 518-522.

Spence, J.D., O.B. Paulson, and S. Strangaard. 2000. Hypertension and Stroke. The ABC's of Antihypertensive Therapy. 2nd ed. F.H. Messerli. New York, NY: Lippincott Williams and Wilkins. 279-296.

Spence, J.D., and K.B. Zarnke. 2000. Stroke and Hypertension. Hypertension: A Companion to Brenner and Rector's The Kidney. S. Oparil, and M.A. Weber. Philadelphia, PA: W.B. Saunders. 266-286.

Taylor, W.D., H.J.M. Barnett, R.B. Haynes, G.G. Ferguson, D.L. Sackett, K.E. Thorpe, D. Simard, F.L. Silver, V.C. Hachinski, G.P. Claggett, R. Barnes, and J.D. Spence. 1999. A randomized trial of low and high dose acetylsalicylic acid for patients undergoing carotid endarterectomy. Lancet 353: 2179-2184.

Thijs, L., J.A. Staessen, H. Celis, R. Fagard, P. De Cort, R. de Gaudemaris, I. Enstrom, Y. Imai, S. Julius, J. Menard, D. Mion, P. Palatini, J. Rosenfeld, D. Shapiro, J.D. Spence, and G. Stergiou. 1999. The international database of self-recorded blood pressures in normotensives and untreated hypertensive subjects. Blood Pressure Monitoring 4: 77-86.

 

STRONG, M.J.

Demaerschalk, B.M., and M.J. Strong. 2000. Amyotrophic lateral scleosis. Current Treatment Options in Neurology 2: 13-22.

Demaerschalk, B.M., and M.J. Strong. 2000. Treatment of Spasticity in ALS. Cochrane Collaboration: Neuromuscular Diseases Section.

He, B., and M.J. Strong. 2000. Motor neuron death in sporadic amyotrophic lateral sclerosis is not apoptotic: A comparative analysis of ALS and chronic aluminum neurotoxicity in New Zealand white rabbits. Journal of Neuropathology and Applied Neurobiology 26: 150-160.

He, B., and M.J. Strong. 2000. Trace metal toxicity and motor neuron disease. Journal of Trace Elements in Experimental Medicine 13: 131-140.

Strong, M.J. 2000. Exogenous Neurotoxins. Amyotrophic Lateral Sclerosis. R.D. Brown, V. Meininger, and M. Swash. London: Martin Dunitz Publisher. 279-287.

Strong, M.J. 1999. Neurofilament metabolism in sporadic amyotrophic lateral sclerosis. Journal of Neurological Science 169: 170-177.

Strong, M.J., G.M. Grace, J.B. Orange, H.A. Leeper, R. Menon, and C. Aere. 1999. A prospective study of cognitive impairment in ALS. Neurology 53: 1665-1670.

Strong, M.J., and G.L. Pattee. 2000. Creatine and coenzyme Q10 in the treatment of ALS. ALS and other Motor Neuron Disorders 1 (Suppl 4): 17-20.

Strong, M.J., A. Rowe, and R.N. Rankin. 1999. Percutaneous gastrojejunostomy in ALS. Journal of Neurological Science 169: 128-132.

Wong, N.K., B.P. He, and M.J. Strong. 2000. Characterization of neuronal intermediate filament protein expression in cervical motor neurons in sporadic amyotrophic lateral sclerosis. Journal of Neuropathology and Experimental Neurology 59: 972-982.

 

WIEBE, S.

Blume, W.T., and S. Wiebe. 2000. Occipital lobe epilepsies. Advances in Neurology: Neocortical Epilepsies 84: 173-187.

Derry, P.E., and S. Wiebe. 2000. Psychological adjustment to success and to failure following epilepsy surgery. Canadian Journal of Neurological Sciences 27 (Suppl 1): 116-120.

Wiebe, S. 2000. Buccal midazolam may be a useful alternative to rectal diazepam for treating acute seizures in refractory epilepsy. ACP Journal Club 132 (1): 22.

Wiebe, S. 1999. Commentary on "Mortality rates were higher in adults with epilepsy, but the risk for dying directly of epilepsy was small". Evidence-based medicine Nov/Dec: 190.

Wiebe, S. 1999. Commentary on "Mortality rates were higher in adults with epilepsy, but the risk for dying directly of epilepsy was small". ACP Journal Club Nov/Dec: 75.

Wiebe, S. 2000. Epidemiology of temporal lobe epilepsy. Canadian Journal of Neurological Sciences 27 (Suppl 1): 6-10.

Wiebe, S. 2000. Managing women with epilepsy. Guideline producers now need to pay attention to implementation. British Medical Journal 320 (7226): 3-4. Editorial.

Wiebe, S. 2000. Seizure control as an indicator of therapeutic usefulness. Canadian Journal of Neurological Sciences 27 (Suppl 1): 97-105.

Wiebe, S., and P.E. Derry. 2000. Measuring quality of life in epilepsy surgery patients. Canadian Journal of Neurological Sciences 27 (Suppl 1): 111-115.

 

YOUNG, G.B.

Bayliff, C., P. Camfield, S. Cowan, A. Guberman, S. Lovell, R.S. McLachlan, and G.B. Young. 1999. Anti-epileptic Drug Treatment. CPS 1999. 34th ed. G. Gillis. Toronto, ON: Webcom. L45-L47.

Bolton, C.F., and G.B. Young. 1999. Hospitalist Neurology. Nephrology. M. Samuels. Boston: Butterworth-Heinemann. 231-254.

Young, G.B., and C.F. Bolton. 1999. Electrophysiologic Evaluation of Patients in the Intensive Care Unit. Electrodiagnosis in Clinical Neurology. 4th ed. M. Aminoff. New York, NY: Churchill Livingston. 655-679.

Young, G.B., and M.W. Nicolle. 1999. Normal Physiology of the Nervous System. Oxford Textbook of Critical Care. A.R. Webb, M. Shapiro, M. Singer, and P.M. Suter. Oxford University Press. 433-437.

Young, G.B., and D.R. Plotkin. 2000. ICU: ineffective communication unit (Editorial). Critical Care Medicine 28: 3116-3117.